Cigna's most recent trend suggests a bullish bias. One trading opportunity on Cigna is a Bull Put Spread using a strike $195.00 short put and a strike $185.00 long put offers a potential 38.89% return on risk over the next 8 calendar days. Maximum profit would be generated if the Bull Put Spread were to expire worthless, which would occur if the stock were above $195.00 by expiration. The full premium credit of $2.80 would be kept by the premium seller. The risk of $7.20 would be incurred if the stock dropped below the $185.00 long put strike price.
The 5-day moving average is moving up which suggests that the short-term momentum for Cigna is bullish and the probability of a rise in share price is higher if the stock starts trending.
The 20-day moving average is moving up which suggests that the medium-term momentum for Cigna is bullish.
The RSI indicator is at 40.25 level which suggests that the stock is neither overbought nor oversold at this time.
To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here
LATEST NEWS for Cigna
AM Best Assigns Issue Credit Ratings to Cigna Corporation’s New Senior Unsecured Notes and Indicative Shelf Registration
Tue, 10 Mar 2020 21:36:00 +0000
AM Best has assigned the Long-Term Issue Credit Ratings (Long-Term IRs) of "bbb" to the $1.5 billion 2.4% senior unsecured notes due 2030, $750 million 3.2% senior unsecured notes due 2040 and the $1.25 billion 3.4% senior unsecured notes due 2050 recently issued by Cigna Corporation (Cigna) (headquartered in Bloomfield, CT) [NYSE:CI]. Furthermore, AM Best has assigned indicative Long-Term IRs of "bbb" to senior unsecured debt and "bb+" to preferred shares under the recently filed shelf registration. The outlook assigned to these Credit Ratings (ratings) is stable. The existing ratings of Cigna and its subsidiaries are unchanged (see related press release).
Pence says private insurers will cover coronavirus treatment, waive test co-pay
Tue, 10 Mar 2020 15:48:14 +0000
Were Hedge Funds Right About Piling Into Cigna Corporation (CI)?
Mon, 09 Mar 2020 21:49:00 +0000
Coronavirus is probably the 1 concern in investors' minds right now. It should be. On February 27th we published this article and predicted that US stocks will go down by at least 20% in the next 3-6 months. We also told you to short the market ETFs and buy long-term bonds. Investors who agreed with […]
CVS Health offers free home delivery of prescription drugs amid virus outbreak
Mon, 09 Mar 2020 19:04:50 +0000
CVS Health Corp said on Monday it would immediately waive charges for home delivery of prescription medications, in response to the U.S. health agencies urging patients to stay at home amid a fast-spreading coronavirus outbreak. This follows the company's announcement on Friday that its health insurance unit, Aetna, will offer all diagnostic testing and telemedicine visits without any patient cost sharing for the next 90 days. Aetna will also waive early refill limits on 30-day prescription maintenance medications for all members with pharmacy benefits administered through CVS Caremark, the company said.
Health insurers could raise premiums next year if coronavirus costs hit financial performance
Sun, 08 Mar 2020 14:14:00 +0000
The cost of health insurance premiums may increase in 2021 if insurers face unexpected costs for treating people with COVID-19, the novel coronavirus that has sickened more than 250 people in the U.S. and killed at least 14 others.
Related Posts
Also on Market Tamer…
Follow Us on Facebook